BMS-986104 Uses, Dosage, Side Effects and more
BMS-986104 is under investigation in clinical trial NCT02211469 (A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986104 in Healthy Male Subjects).
| Trade Name | BMS-986104 |
| Generic | BMS-986104 |
| Type | |
| Formula | C22H35NO |
| Weight | Average: 329.528 Monoisotopic: 329.271864751 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
